Reform at the FDA—in need of reform

14 January 2020 - On 23 December 2016, the US FDA announced the approval of nusinersen, the first drug for the ...

Read more →

TLV has decided to reconsider the subsidy for Xeljanz

14 January 2020 - When TLV decided that Xeljanz should be included in the high-cost protection, this was justified by the ...

Read more →

Human medicines: highlights of 2019

9 January 2020 - EMA has published a review of its key recommendations in 2019 on the authorisation and safety ...

Read more →

PBAC – 2019 in review

8 January 2020 - The PBAC considered 188 submissions in 2019. ...

Read more →

Novel drug approvals for 2019

2 January 2020 - How many of the 'novel' drugs approved by the FDA in 2019 are actually new medicines in ...

Read more →

The use of risk-sharing contracts in health care: theoretical and empirical assessments

3 December 2019 - The aim of this review is to provide a summary of the literature on risk-sharing agreements, including ...

Read more →

The ‘Top 10’ challenges for health technology assessment: INAHTA viewpoint

28 November 2019 - The International Network of Agencies for Health Technology Assessment (INAHTA) spans the globe as a network of ...

Read more →

Biostatistics: a fundamental discipline at the core of modern health data science

28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...

Read more →

High health care costs suggest review is needed: report

8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...

Read more →

ICER identifies costliest US drug-price hikes that are not supported by new clinical evidence

8 October 2019 - In 2017 and 2018, out of nine identified drugs that had substantial price increases on top of ...

Read more →

Bad diagnosis: health care system muddled, lacking leadership major report finds

3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...

Read more →

An international perspective on the paradoxes of US health care

28 August 2019 - Each year, the Commonwealth Fund selects an international cohort of Harkness Fellows in health care policy ...

Read more →

Academics and researchers raise concerns with FDA’s plan for ‘integrated reviews’

28 August 2019 - More than 50 academics and researchers from Harvard, Yale, Johns Hopkins and other universities around the ...

Read more →

Australian Public Assessment Reports for prescription medicines

28 August 2019 - TGA is reviewing the operation of transparency measures and are considering activities to increase transparency of ...

Read more →

Patient Voice Aotearoa calls for PHARMAC reform

28 August 2019 - Patient Voice Aotearoa has launched a petition calling for the Minister of Health to initiate an ...

Read more →